Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma for hospitalized COVID-19 patients
IRCT20151228025732N53Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Apr 2020
- Countries
- 1
01
Overview
Phase 3, open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Semnan University of Medical Sciences. Primary endpoints: Amount of ventilation, White blood cell count and 3 more. Started Apr 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20151228025732N53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151228025732N53.